Clinical trial
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
NCT00406991 · Schepens Eye Research Institute, Other · Completed
Key facts
| NCT number | NCT00406991 |
|---|---|
| Title | Retinal Blood Flow and Microthrombi in Type 1 Diabetes |
| Official title | Retinal Blood Flow and Microthrombi in Type 1 Diabetes |
| Lead sponsor | Schepens Eye Research Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetic Retinopathy |
| Intervention type | Drug |
| Interventions | aspirin, clopidogrel |
| Enrollment | 100 |
| Start date | Jun 1, 2003 |
| Completion | Mar 1, 2006 |
| First posted | Dec 4, 2006 |
| Last update posted | Oct 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: